The overall burden of drug development has increased exponentially over the last decade or so. Consequentially, the global health care economics is being strained both in developed and in developing nations around the world. With pharmacoeconomics and Pay for Performance gaining universal accOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.